Efficacy About Pulmonary Fibrosis Expert View RA-ILD risk calculator Previous Next Previous Play Next Progressive Pulmonary Fibrosis: Diagnosis & Treatment in the ATS/ERS/JRS/ALAT Guideline 16/02/2023 | Author: Boehringer Ingelheim Document ID: PC-MY-102902 Efficacy A1-R101||A2-R101||INBUILD® Trial Efficacy (RA-ILD Subgroup Analysis) by Dr E. Volkmann Progressive Pulmonary Fibrosis: Diagnosis & Treatment in the ATS/ERS/JRS/ALAT Guideline Progressive Pulmonary Fibrosis: focus on autoimmune ILDs RELATED CONTENT Read more 3:53 INBUILD® Trial Efficacy (RA-ILD Subgroup Analysis) by Dr E. Volkmann Watch now Opens in new tab Read more PDF Progressive Pulmonary Fibrosis: focus on autoimmune ILDs Download Opens in new tab Home Inflammation nintedanib Efficacy Progressive Pulmonary Fibrosis: Diagnosis & Treatment in the ATS/ERS/JRS/ALAT Guideline
Read more 3:53 INBUILD® Trial Efficacy (RA-ILD Subgroup Analysis) by Dr E. Volkmann Watch now Opens in new tab